Updated:
AbbVie Biotech Ventures
AbbVie Biotech Ventures was established in 2013. It functions as the corporate venture arm of AbbVie, a global biopharmaceutical company. The vehicle pursues...
AbbVie Biotech Ventures
AbbVie Biotech Ventures was established in 2013. It functions as the corporate venture arm of AbbVie, a global biopharmaceutical company. The vehicle pursues early-stage and growth investments in biotechnology. Confirmed strategies include seed and venture deployments. Geographic reach centers on North America. Team size and additional offices remain undisclosed in available records. No dated operational events from the last 24 months appear in the source material. The structure ties directly to AbbVie corporate operations with no separate family or external LP mandate disclosed.
General information
Firm type
Venture Capital
Year founded
2013
Location
Region
North America
Country
United States
City
North Chicago
Corporate office
One North Waukegan Road, North Chicago, IL, United States
Sector focus
Frequently asked questions
Who runs investment decisions at AbbVie Biotech Ventures?
No named principals or investment committee members are disclosed in the source records.
Does AbbVie Biotech Ventures participate in fund commitments or only direct deals?
Source material indicates direct early-stage investments but provides no detail on fund commitments or co-investors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: